glp-1 drugs and addiction Not just obesity: receptor agonists advance on How GLP-1 Can Help in
Description
SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes
baseline and placebo, and YKL-40, ICAM-1, and leptin vs
BBB, Blood-Brain Barrier
Search terms included combinations of autoimmune thyroid disease, Hashimoto thyroiditis, Graves disease, thyroid autoimmunity, GLP-1 receptor agonist, semaglutide, tirzepatide, incretin therapy, immunometabolism, and metabolic inflammation
2.2 Eligibility criteria Inclusion criteria: Study design: Randomized controlled trials (RCTs) with either placebo or active comparator arms
doi: 10.3389/fnmol.2018.00002
